查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
ASR 和 RUO 市场 - 成长、未来展望和竞争分析，2025 年至 2033 年
市场调查报告书
商品编码
1684733

ASR 和 RUO 市场 - 成长、未来展望和竞争分析，2025 年至 2033 年

ASRs and RUOs Market - Growth, Future Prospects and Competitive Analysis, 2025 - 2033
出版日期: | 出版商: Acute Market Reports | 英文 170 Pages | 商品交期: 最快1-2个工作天内

价格

ASR（分析特异性试剂）和 RUO（仅供研究使用）市场包括涉及特定化学和生物成分的生产和分销的诊断和研究行业部分。这些组件用于创建临床测试，对于诊断检测的开发至关重要。虽然 ASR 对于检测临床样本中的特定分析物至关重要，但 RUO 仅用于研究目的的产品，未核准用于临床或诊断用途。由于精密诊断工具的需求不断增加以及生物医学和临床研究的快速进步，ASR 和 RUO 市场正在经历显着成长。 ASR对于客製化诊断试剂套件的开发至关重要，特别是在感染疾病、肿瘤学和遗传疾病领域。另一方面，RUO 在研究环境中发挥重要作用，促进了新科学知识和临床实验室方法的发展。预测期内，全球 ASR 和 RUO 市场规模预计将以 4.9% 的复合年增长率成长。这一增长的推动因素包括医疗保健研究投入的增加、需要不断诊断创新的慢性病发病率的上升以及生物技术产业的成长。

ASR 和 RUO 市场在很大程度上受到个人化医疗兴起的推动，个人化医疗严重依赖特定的诊断测试来根据个别患者的特征制定治疗方案。个人化医疗的重要性日益增加，原因在于它能够提高治疗效果和患者预后，特别是在肿瘤学和遗传疾病领域，客製化治疗至关重要。使用 ASR 开发此类客製化诊断工具将能够准确检测和监测与特定疾病相关的生物标记物，从而促进标靶治疗方案。随着医疗保健系统越来越多地采用个人化治疗方法，对 ASR 等高度特异性和敏感性诊断组件的需求正在激增，从而推动了诊断市场这一领域的显着增长。

基因组学研究的进步为 ASR 和 RUO 市场提供了重大机会。定序技术和生物资讯学的快速发展使得对可用于复杂基因分析和研究的专用试剂的需求日益增加。特别是，RUO 在实验室环境中发挥着至关重要的作用，使研究人员能够开发和改进新的检测方法，然后将其转化为临床用途。基因组学的持续创新不仅将拓宽 ASR 和 RUO 的应用范围，而且还将确保持续的需求，因为研究人员和医疗保健提供者寻求发现新的遗传见解并将其应用于医疗诊断和治疗策略。

本报告研究了全球 ASR 和 RUO 市场，并提供了市场概述以及按产品类型、最终用户和地区分類的趋势，以及参与市场的公司概况。

目录

第 1 章 简介

第 2 章执行摘要

3. ASR 与 RUO 市场竞争分析

  • 主要供应商的市场定位
  • 供应商所采用的策略
  • 重大产业战略

第 4 章 ASR 与 RUO 市场：宏观分析与市场动态

  • 介绍
  • 全球 ASR 与 RUO 市值：2023-2033 年
  • 市场动态
  • 驾驶员和约束影响分析
  • 跷跷板分析
  • 波特五力模型
  • PESTEL 分析

5. 依产品类型分類的 ASR 和 RUO 市场（2023-2033 年）

  • 市场概况
  • 成长与收益分析：2024 年与 2033 年
  • 市场区隔

6. 依最终用户分類的 ASR 和 RUO 市场（2023-2033 年）

  • 市场概况
  • 成长与收益分析：2024 年与 2033 年
  • 市场区隔

7. 北美 ASR 与 RUO 市场（2023-2033）

第 8 章。英国及欧盟 ASR 及 RUO 市场（2023-2033 年）

9. 亚太地区 ASR 与 RUO 市场（2023-2033 年）

第 10 章拉丁美洲 ASR 与 RUO 市场（2023-2033 年）

11. 中东和非洲 ASR 和 RUO 市场（2023-2033）

第十二章 公司简介

  • BioLegend Inc.
  • ELITechGroup
  • BD
  • bioMerieux Inc.
  • Genetic Signatures
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • DiaSorin Molecular LLC
  • LGC Biosearch Technologies
  • altona Diagnostics GmbH
  • QIAGEN
Product Code: 141259-01-25

The ASRs (Analyte Specific Reagents) and RUOs (Research Use Only) market comprises segments of the diagnostics and research industry involved with the production and distribution of specific chemical and biological components. These components are used in the creation of laboratory tests and are essential in the development of diagnostic assays. ASRs are critical for detecting specific analytes in clinical samples, while RUOs are products intended solely for research purposes and are not approved for clinical or diagnostic use. The ASRs and RUOs market is experiencing significant growth, driven by the expanding demand for precise diagnostic tools and the rapid advancement of research in the biomedical and clinical fields. ASRs are vital for developing customized diagnostic kits, especially in the areas of infectious diseases, oncology, and genetic disorders. Meanwhile, RUOs play a crucial role in research environments, facilitating the development of new scientific knowledge and clinical testing methodologies. The global market is projected to grow at a compound annual growth rate (CAGR) of 4.9% over the forecast period. This growth is supported by increasing investments in healthcare research, rising prevalence of chronic diseases necessitating ongoing diagnostic innovations, and the growing biotechnology industry.

Driver: Expansion of Personalized Medicine

The ASRs and RUOs market is significantly driven by the expansion of personalized medicine, which relies heavily on specific diagnostic tests to tailor treatment to individual patient characteristics. Personalized medicine's growing importance is underscored by its capacity to improve treatment efficacy and patient outcomes, especially in oncology and genetic disorders where treatment customization is crucial. The use of ASRs in developing these bespoke diagnostic tools allows for precise detection and monitoring of biomarkers related to specific diseases, thereby facilitating targeted therapy regimens. As healthcare systems increasingly adopt personalized treatment approaches, the demand for highly specific and sensitive diagnostic components, such as ASRs, surges, fostering substantial growth in this segment of the diagnostics market.

Opportunity: Advances in Genomic Research

Advances in genomic research present significant opportunities for the ASRs and RUOs market. With the rapid evolution of sequencing technologies and bioinformatics, there is a heightened need for specialized reagents that can be employed in complex genetic analyses and research. RUOs, in particular, are crucial in experimental settings, helping researchers develop and refine new assays that may later transition to clinical use. This ongoing innovation in genomics not only broadens the application scope of ASRs and RUOs but also ensures a continuous demand as researchers and healthcare providers seek to uncover new genetic insights and apply these to medical diagnostics and treatment strategies.

Restraint: Regulatory Challenges

Regulatory challenges pose a significant restraint to the ASRs and RUOs market. The stringent regulations governing the use and approval of diagnostic reagents can impede the development and commercialization of new ASRs. In many jurisdictions, ASRs must meet rigorous safety and efficacy standards before they can be integrated into clinical settings, which can prolong the development timeline and increase costs. For RUOs, the limitation is in their use; being restricted to research settings, their transition to clinical applications is often fraught with regulatory hurdles. These challenges can deter investment in new product development and limit the availability of innovative diagnostic solutions in the market.

Challenge: Keeping Pace with Rapid Technological Advancements

A major challenge for the ASRs and RUOs market is keeping pace with rapid technological advancements in medical research and diagnostics. The swift evolution of technologies often outstrips the development cycle of new reagents, creating a lag in the availability of specific reagents tailored to the latest diagnostic platforms or research techniques. This gap can hinder the timely application of breakthrough technologies in clinical and research settings, potentially delaying the benefits they could bring to patient care and scientific discovery. For companies in the ASRs and RUOs market, continuously adapting and innovating to match these technological strides is essential yet challenging, requiring substantial ongoing investment in R&D and a flexible approach to product development.

Market Segmentation by Product Type

In the ASRs and RUOs market, the product types are segmented into Analyte Specific Reagents (ASRs) and Research Use Only Products (RUOs). Analyte Specific Reagents are projected to command the highest revenue within the market, owing to their critical role in clinical diagnostics and the growing demand for precise, personalized medical tests. These reagents are essential for developing highly specific assays that are tailored to detect particular biomarkers, thus supporting advanced diagnostic procedures and personalized medicine approaches in human healthcare. On the other hand, Research Use Only Products are expected to witness the highest CAGR from 2025 to 2033. This growth is driven by the escalating pace of biomedical research and the expanding need for specialized reagents that can facilitate complex experimental protocols, particularly in genomics and proteomics research. The increasing investment in research activities by biotechnological and pharmaceutical companies further fuels the demand for RUOs, aligning with the industry's push towards innovative drug development and therapeutic techniques.

Market Segmentation by End-user Application

The market segmentation by end-user application in the ASRs and RUOs market covers Human Healthcare, Veterinary, Environmental, Food Industry, Academic & Research Institutes, and Others. Human Healthcare is expected to continue dominating the market in terms of revenue due to the extensive use of ASRs and RUOs in developing diagnostic tests and therapies tailored to individual health needs. The segment benefits from the high volume of clinical diagnostics performed and the significant investments in healthcare infrastructure and diagnostic technologies. Conversely, Academic & Research Institutes are anticipated to experience the highest CAGR over the forecast period. This sector's growth is propelled by the intensifying research activities in life sciences, where ASRs and RUOs are extensively utilized to explore new scientific territories and develop innovative health solutions. The surge in funding for academic research and the rising collaboration between educational institutions and the biotech industry also contribute to the rapid growth of this segment, highlighting its pivotal role in advancing medical science and technology.

Geographic Segment

The ASRs and RUOs market exhibits distinct geographic trends, with North America currently holding the highest revenue share due to its advanced healthcare infrastructure, substantial biomedical research funding, and stringent regulatory standards which drive demand for high-quality ASRs and RUOs. The region's dominance is supported by the presence of leading biotech and pharmaceutical companies and numerous research institutions that continuously require advanced diagnostic and research tools. However, the Asia-Pacific region is expected to register the highest CAGR from 2025 to 2033. This surge is attributed to the rapid expansion of healthcare facilities, increasing government initiatives in healthcare research, and growing partnerships between global and local biotech firms in countries like China and India. The region's booming healthcare industry, coupled with its rising focus on chronic diseases and personalized medicine, is driving the demand for specialized diagnostic reagents and research products.

Competitive Trends and Key Strategies

In 2024, the competitive landscape of the ASRs and RUOs market was characterized by strategic collaborations, mergers, and acquisitions, as well as significant investments in R&D by key players like BioLegend, Inc., ELITechGroup, BD, bioMerieux, Inc., Genetic Signatures, Thermo Fisher Scientific, Inc., Danaher Corporation, DiaSorin Molecular LLC, LGC Biosearch Technologies, altona Diagnostics GmbH, and QIAGEN. These companies focused on expanding their product portfolios and enhancing their global footprint through strategic alliances and new product developments tailored to meet the evolving needs of the healthcare and research sectors. For instance, Thermo Fisher Scientific and Danaher led in innovation, introducing new ASRs and RUOs that promise greater accuracy and sensitivity, catering to the advanced requirements of genomic and proteomic research. Moving forward, from 2025 to 2033, these companies are expected to leverage their strengths in technology and global distribution networks to penetrate emerging markets. The focus will likely remain on enhancing product capabilities and meeting the stringent regulatory requirements across different regions, ensuring their competitive edge. The market is poised for dynamic changes with companies continuously adapting to the technological advancements and shifting focus of healthcare towards more personalized and precision-based diagnostics, which will significantly shape the competitive dynamics and strategic directions of these leading players.

Historical & Forecast Period

This study report represents an analysis of each segment from 2023 to 2033 considering 2024 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2025 to 2033.

The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of ASRs and RUOs market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users & consumption volume, price, and value.

Geographical revenues generated by countries considered in the report

Micro and macro environment factors that are currently influencing the ASRs and RUOs market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

Market Segmentation

  • Product Type
  • Analyte Specific Reagents
  • Research Use Only Products
  • End-user by Application
  • Human Healthcare
  • Veterinary
  • Environmental
  • Food Industry
  • Academic & Research Institutes
  • Others
  • Region Segment (2023-2033; US$ Million)
  • North America
  • U.S.
  • Canada
  • Rest of North America
  • UK and European Union
  • UK
  • Germany
  • Spain
  • Italy
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East and Africa
  • GCC
  • Africa
  • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of ASRs and RUOs market?
  • What are the key investment pockets concerning product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2033.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the ASRs and RUOs market?
  • Which is the largest regional market for ASRs and RUOs market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving ASRs and RUOs market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the ASRs and RUOs market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global ASRs and RUOs Market
  • 2.2. Global ASRs and RUOs Market, By Product Type, 2024 (US$ Million)
  • 2.3. Global ASRs and RUOs Market, By End-user, 2024 (US$ Million)
  • 2.4. Global ASRs and RUOs Market, By Geography, 2024 (US$ Million)
  • 2.5. Attractive Investment Proposition by Geography, 2024

3. ASRs and RUOs Market: Competitive Analysis

  • 3.1. Market Positioning of Key ASRs and RUOs Market Vendors
  • 3.2. Strategies Adopted by ASRs and RUOs Market Vendors
  • 3.3. Key Industry Strategies

4. ASRs and RUOs Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global ASRs and RUOs Market Value, 2023 - 2033, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. ASRs and RUOs Market: By Product Type, 2023-2033, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2024 Versus 2033
  • 5.3. Market Segmentation
    • 5.3.1. Analyte Specific Reagents
    • 5.3.2. Research Use Only Products

6. ASRs and RUOs Market: By End-user, 2023-2033, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2024 Versus 2033
  • 6.3. Market Segmentation
    • 6.3.1. Human Healthcare
    • 6.3.2. Veterinary
    • 6.3.3. Environmental
    • 6.3.4. Food Industry
    • 6.3.5. Academic & Research Institutes
    • 6.3.6. Others

7. North America ASRs and RUOs Market, 2023-2033, USD (Million)

  • 7.1. Market Overview
  • 7.2. ASRs and RUOs Market: By Product Type, 2023-2033, USD (Million)
  • 7.3. ASRs and RUOs Market: By End-user, 2023-2033, USD (Million)
  • 7.4.ASRs and RUOs Market: By Region, 2023-2033, USD (Million)
    • 7.4.1.North America
      • 7.4.1.1. U.S.
        • 7.4.1.1.1. ASRs and RUOs Market: By Product Type, 2023-2033, USD (Million)
        • 7.4.1.1.2. ASRs and RUOs Market: By End-user, 2023-2033, USD (Million)
      • 7.4.1.2. Canada
        • 7.4.1.2.1. ASRs and RUOs Market: By Product Type, 2023-2033, USD (Million)
        • 7.4.1.2.2. ASRs and RUOs Market: By End-user, 2023-2033, USD (Million)
      • 7.4.1.3. Rest of North America
        • 7.4.1.3.1. ASRs and RUOs Market: By Product Type, 2023-2033, USD (Million)
        • 7.4.1.3.2. ASRs and RUOs Market: By End-user, 2023-2033, USD (Million)

8. UK and European Union ASRs and RUOs Market, 2023-2033, USD (Million)

  • 8.1. Market Overview
  • 8.2. ASRs and RUOs Market: By Product Type, 2023-2033, USD (Million)
  • 8.3. ASRs and RUOs Market: By End-user, 2023-2033, USD (Million)
  • 8.4.ASRs and RUOs Market: By Region, 2023-2033, USD (Million)
    • 8.4.1.UK and European Union
      • 8.4.1.1. UK
        • 8.4.1.1.1. ASRs and RUOs Market: By Product Type, 2023-2033, USD (Million)
        • 8.4.1.1.2. ASRs and RUOs Market: By End-user, 2023-2033, USD (Million)
      • 8.4.1.2. Germany
        • 8.4.1.2.1. ASRs and RUOs Market: By Product Type, 2023-2033, USD (Million)
        • 8.4.1.2.2. ASRs and RUOs Market: By End-user, 2023-2033, USD (Million)
      • 8.4.1.3. Spain
        • 8.4.1.3.1. ASRs and RUOs Market: By Product Type, 2023-2033, USD (Million)
        • 8.4.1.3.2. ASRs and RUOs Market: By End-user, 2023-2033, USD (Million)
      • 8.4.1.4. Italy
        • 8.4.1.4.1. ASRs and RUOs Market: By Product Type, 2023-2033, USD (Million)
        • 8.4.1.4.2. ASRs and RUOs Market: By End-user, 2023-2033, USD (Million)
      • 8.4.1.5. France
        • 8.4.1.5.1. ASRs and RUOs Market: By Product Type, 2023-2033, USD (Million)
        • 8.4.1.5.2. ASRs and RUOs Market: By End-user, 2023-2033, USD (Million)
      • 8.4.1.6. Rest of Europe
        • 8.4.1.6.1. ASRs and RUOs Market: By Product Type, 2023-2033, USD (Million)
        • 8.4.1.6.2. ASRs and RUOs Market: By End-user, 2023-2033, USD (Million)

9. Asia Pacific ASRs and RUOs Market, 2023-2033, USD (Million)

  • 9.1. Market Overview
  • 9.2. ASRs and RUOs Market: By Product Type, 2023-2033, USD (Million)
  • 9.3. ASRs and RUOs Market: By End-user, 2023-2033, USD (Million)
  • 9.4.ASRs and RUOs Market: By Region, 2023-2033, USD (Million)
    • 9.4.1.Asia Pacific
      • 9.4.1.1. China
        • 9.4.1.1.1. ASRs and RUOs Market: By Product Type, 2023-2033, USD (Million)
        • 9.4.1.1.2. ASRs and RUOs Market: By End-user, 2023-2033, USD (Million)
      • 9.4.1.2. Japan
        • 9.4.1.2.1. ASRs and RUOs Market: By Product Type, 2023-2033, USD (Million)
        • 9.4.1.2.2. ASRs and RUOs Market: By End-user, 2023-2033, USD (Million)
      • 9.4.1.3. India
        • 9.4.1.3.1. ASRs and RUOs Market: By Product Type, 2023-2033, USD (Million)
        • 9.4.1.3.2. ASRs and RUOs Market: By End-user, 2023-2033, USD (Million)
      • 9.4.1.4. Australia
        • 9.4.1.4.1. ASRs and RUOs Market: By Product Type, 2023-2033, USD (Million)
        • 9.4.1.4.2. ASRs and RUOs Market: By End-user, 2023-2033, USD (Million)
      • 9.4.1.5. South Korea
        • 9.4.1.5.1. ASRs and RUOs Market: By Product Type, 2023-2033, USD (Million)
        • 9.4.1.5.2. ASRs and RUOs Market: By End-user, 2023-2033, USD (Million)
      • 9.4.1.6. Rest of Asia Pacific
        • 9.4.1.6.1. ASRs and RUOs Market: By Product Type, 2023-2033, USD (Million)
        • 9.4.1.6.2. ASRs and RUOs Market: By End-user, 2023-2033, USD (Million)

10. Latin America ASRs and RUOs Market, 2023-2033, USD (Million)

  • 10.1. Market Overview
  • 10.2. ASRs and RUOs Market: By Product Type, 2023-2033, USD (Million)
  • 10.3. ASRs and RUOs Market: By End-user, 2023-2033, USD (Million)
  • 10.4.ASRs and RUOs Market: By Region, 2023-2033, USD (Million)
    • 10.4.1.Latin America
      • 10.4.1.1. Brazil
        • 10.4.1.1.1. ASRs and RUOs Market: By Product Type, 2023-2033, USD (Million)
        • 10.4.1.1.2. ASRs and RUOs Market: By End-user, 2023-2033, USD (Million)
      • 10.4.1.2. Mexico
        • 10.4.1.2.1. ASRs and RUOs Market: By Product Type, 2023-2033, USD (Million)
        • 10.4.1.2.2. ASRs and RUOs Market: By End-user, 2023-2033, USD (Million)
      • 10.4.1.3. Rest of Latin America
        • 10.4.1.3.1. ASRs and RUOs Market: By Product Type, 2023-2033, USD (Million)
        • 10.4.1.3.2. ASRs and RUOs Market: By End-user, 2023-2033, USD (Million)

11. Middle East and Africa ASRs and RUOs Market, 2023-2033, USD (Million)

  • 11.1. Market Overview
  • 11.2. ASRs and RUOs Market: By Product Type, 2023-2033, USD (Million)
  • 11.3. ASRs and RUOs Market: By End-user, 2023-2033, USD (Million)
  • 11.4.ASRs and RUOs Market: By Region, 2023-2033, USD (Million)
    • 11.4.1.Middle East and Africa
      • 11.4.1.1. GCC
        • 11.4.1.1.1. ASRs and RUOs Market: By Product Type, 2023-2033, USD (Million)
        • 11.4.1.1.2. ASRs and RUOs Market: By End-user, 2023-2033, USD (Million)
      • 11.4.1.2. Africa
        • 11.4.1.2.1. ASRs and RUOs Market: By Product Type, 2023-2033, USD (Million)
        • 11.4.1.2.2. ASRs and RUOs Market: By End-user, 2023-2033, USD (Million)
      • 11.4.1.3. Rest of Middle East and Africa
        • 11.4.1.3.1. ASRs and RUOs Market: By Product Type, 2023-2033, USD (Million)
        • 11.4.1.3.2. ASRs and RUOs Market: By End-user, 2023-2033, USD (Million)

12. Company Profile

  • 12.1. BioLegend, Inc.
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Portfolio
    • 12.1.4. Strategic Initiatives
  • 12.2. ELITechGroup
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Portfolio
    • 12.2.4. Strategic Initiatives
  • 12.3. BD
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Portfolio
    • 12.3.4. Strategic Initiatives
  • 12.4. bioMerieux, Inc.
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Portfolio
    • 12.4.4. Strategic Initiatives
  • 12.5. Genetic Signatures
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Portfolio
    • 12.5.4. Strategic Initiatives
  • 12.6. Thermo Fisher Scientific, Inc.
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Portfolio
    • 12.6.4. Strategic Initiatives
  • 12.7. Danaher Corporation
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Portfolio
    • 12.7.4. Strategic Initiatives
  • 12.8. DiaSorin Molecular LLC
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Portfolio
    • 12.8.4. Strategic Initiatives
  • 12.9. LGC Biosearch Technologies
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Portfolio
    • 12.9.4. Strategic Initiatives
  • 12.10. altona Diagnostics GmbH
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Portfolio
    • 12.10.4. Strategic Initiatives
  • 12.11. QIAGEN
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Portfolio
    • 12.11.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global ASRs and RUOs Market By Product Type, 2023-2033, USD (Million)
  • TABLE 2 Global ASRs and RUOs Market By End-user by Application, 2023-2033, USD (Million)
  • TABLE 3 North America ASRs and RUOs Market By Product Type, 2023-2033, USD (Million)
  • TABLE 4 North America ASRs and RUOs Market By End-user by Application, 2023-2033, USD (Million)
  • TABLE 5 U.S. ASRs and RUOs Market By Product Type, 2023-2033, USD (Million)
  • TABLE 6 U.S. ASRs and RUOs Market By End-user by Application, 2023-2033, USD (Million)
  • TABLE 7 Canada ASRs and RUOs Market By Product Type, 2023-2033, USD (Million)
  • TABLE 8 Canada ASRs and RUOs Market By End-user by Application, 2023-2033, USD (Million)
  • TABLE 9 Rest of North America ASRs and RUOs Market By Product Type, 2023-2033, USD (Million)
  • TABLE 10 Rest of North America ASRs and RUOs Market By End-user by Application, 2023-2033, USD (Million)
  • TABLE 11 UK and European Union ASRs and RUOs Market By Product Type, 2023-2033, USD (Million)
  • TABLE 12 UK and European Union ASRs and RUOs Market By End-user by Application, 2023-2033, USD (Million)
  • TABLE 13 UK ASRs and RUOs Market By Product Type, 2023-2033, USD (Million)
  • TABLE 14 UK ASRs and RUOs Market By End-user by Application, 2023-2033, USD (Million)
  • TABLE 15 Germany ASRs and RUOs Market By Product Type, 2023-2033, USD (Million)
  • TABLE 16 Germany ASRs and RUOs Market By End-user by Application, 2023-2033, USD (Million)
  • TABLE 17 Spain ASRs and RUOs Market By Product Type, 2023-2033, USD (Million)
  • TABLE 18 Spain ASRs and RUOs Market By End-user by Application, 2023-2033, USD (Million)
  • TABLE 19 Italy ASRs and RUOs Market By Product Type, 2023-2033, USD (Million)
  • TABLE 20 Italy ASRs and RUOs Market By End-user by Application, 2023-2033, USD (Million)
  • TABLE 21 France ASRs and RUOs Market By Product Type, 2023-2033, USD (Million)
  • TABLE 22 France ASRs and RUOs Market By End-user by Application, 2023-2033, USD (Million)
  • TABLE 23 Rest of Europe ASRs and RUOs Market By Product Type, 2023-2033, USD (Million)
  • TABLE 24 Rest of Europe ASRs and RUOs Market By End-user by Application, 2023-2033, USD (Million)
  • TABLE 25 Asia ASRs and RUOs Market By Product Type, 2023-2033, USD (Million)
  • TABLE 26 Asia ASRs and RUOs Market By End-user by Application, 2023-2033, USD (Million)
  • TABLE 27 China ASRs and RUOs Market By Product Type, 2023-2033, USD (Million)
  • TABLE 28 China ASRs and RUOs Market By End-user by Application, 2023-2033, USD (Million)
  • TABLE 29 Japan ASRs and RUOs Market By Product Type, 2023-2033, USD (Million)
  • TABLE 30 Japan ASRs and RUOs Market By End-user by Application, 2023-2033, USD (Million)
  • TABLE 31 India ASRs and RUOs Market By Product Type, 2023-2033, USD (Million)
  • TABLE 32 India ASRs and RUOs Market By End-user by Application, 2023-2033, USD (Million)
  • TABLE 33 Australia ASRs and RUOs Market By Product Type, 2023-2033, USD (Million)
  • TABLE 34 Australia ASRs and RUOs Market By End-user by Application, 2023-2033, USD (Million)
  • TABLE 35 South Korea ASRs and RUOs Market By Product Type, 2023-2033, USD (Million)
  • TABLE 36 South Korea ASRs and RUOs Market By End-user by Application, 2023-2033, USD (Million)
  • TABLE 37 Latin America ASRs and RUOs Market By Product Type, 2023-2033, USD (Million)
  • TABLE 38 Latin America ASRs and RUOs Market By End-user by Application, 2023-2033, USD (Million)
  • TABLE 39 Brazil ASRs and RUOs Market By Product Type, 2023-2033, USD (Million)
  • TABLE 40 Brazil ASRs and RUOs Market By End-user by Application, 2023-2033, USD (Million)
  • TABLE 41 Mexico ASRs and RUOs Market By Product Type, 2023-2033, USD (Million)
  • TABLE 42 Mexico ASRs and RUOs Market By End-user by Application, 2023-2033, USD (Million)
  • TABLE 43 Rest of Latin America ASRs and RUOs Market By Product Type, 2023-2033, USD (Million)
  • TABLE 44 Rest of Latin America ASRs and RUOs Market By End-user by Application, 2023-2033, USD (Million)
  • TABLE 45 Middle East and Africa ASRs and RUOs Market By Product Type, 2023-2033, USD (Million)
  • TABLE 46 Middle East and Africa ASRs and RUOs Market By End-user by Application, 2023-2033, USD (Million)
  • TABLE 47 GCC ASRs and RUOs Market By Product Type, 2023-2033, USD (Million)
  • TABLE 48 GCC ASRs and RUOs Market By End-user by Application, 2023-2033, USD (Million)
  • TABLE 49 Africa ASRs and RUOs Market By Product Type, 2023-2033, USD (Million)
  • TABLE 50 Africa ASRs and RUOs Market By End-user by Application, 2023-2033, USD (Million)
  • TABLE 51 Rest of Middle East and Africa ASRs and RUOs Market By Product Type, 2023-2033, USD (Million)
  • TABLE 52 Rest of Middle East and Africa ASRs and RUOs Market By End-user by Application, 2023-2033, USD (Million)

List of Figures

  • FIG. 1 Global ASRs and RUOs Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global ASRs and RUOs Market: Quality Assurance
  • FIG. 5 Global ASRs and RUOs Market, By Product Type, 2024
  • FIG. 6 Global ASRs and RUOs Market, By End-user by Application, 2024
  • FIG. 7 Global ASRs and RUOs Market, By Geography, 2024
  • FIG. 8 Market Geographical Opportunity Matrix - Global ASRs and RUOs Market, 2024
  • FIG. 9Market Positioning of Key ASRs and RUOs Market Players, 2024
  • FIG. 10 Global ASRs and RUOs Market, By Product Type, 2024 Vs 2033, %
  • FIG. 11 Global ASRs and RUOs Market, By End-user by Application, 2024 Vs 2033, %